This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (40)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Genetic Counseling/ Testing/ Therapy  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Development and Validation of an Efficient Approach to Genotyping in Clinical Practice

Carlo Napolitano, MD, PhD; Silvia G. Priori, MD, PhD; Peter J. Schwartz, MD; Raffaella Bloise, MD; Elena Ronchetti, PhD; Janni Nastoli, BS; Georgia Bottelli, BS; Marina Cerrone, MD; Sergio Leonardi, MD

JAMA. 2005;294:2975-2980.

Context  In long QT syndrome (LQTS), disease severity and response to therapy vary according to the genetic loci. There exists a critical need to devise strategies to expedite genetic analysis.

Objective  To perform genetic screening in patients with LQTS to determine the yield of genetic testing, as well as the type and the prevalence of mutations.

Design, Patients, and Setting  We investigated whether the detection of a set of frequently mutated codons in the KCNQ1, KCNH2, and SCN5A genes may translate in a novel strategy for rapid efficient genetic testing of 430 consecutive patients referred to our center between June 1996 and June 2004. The entire coding regions of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 were screened by denaturing high-performance liquid chromatography and DNA sequencing. The frequency and the type of mutations were defined to identify a set of recurring mutations. A separate cohort of 75 consecutive probands was used as a validation group to quantify prospectively the prevalence of the recurring mutations identified in the primary LQTS population.

Main Outcome Measures  Development of a novel approach to LQTS genotyping.

Results  We identified 235 different mutations, 138 of which were novel, in 310 (72%) of 430 probands (49% KCNQ1, 39% KCNH2, 10% SCN5A, 1.7% KCNE1, and 0.7% KCNE2). Fifty-eight percent of probands carried nonprivate mutations in 64 codons of KCNQ1, KCNH2, and SCN5A genes. A similar occurrence of mutations at these codons (52%) was confirmed in the prospective cohort of 75 probands and in previously published LQTS cohorts.

Conclusions  We have developed an approach to improve the efficiency of genetic screening for LQTS. This novel method may facilitate wider access to genotyping resulting in better risk stratification and treatment of LQTS patients.

Author Affiliations: Molecular Cardiology, IRCCS Fondazione S. Maugeri Foundation (Drs Napolitano, Priori, Bloise, Ronchetti, Cerrone, and Leonardi and Mss Nastoli and Bottelli); Department of Cardiology, University of Pavia (Drs Priori and Schwartz); and IRCCS Policlinico S. Matteo (Dr Schwartz), Pavia, Italy.

RELATED ARTICLE

Efficient Genotyping for Congenital Long QT Syndrome
Elizabeth S. Kaufman
JAMA. 2005;294(23):3027-3028.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Congenital long QT syndrome: considerations for primary care physicians.
LEVINE et al.
Cleveland Clinic Journal of Medicine 2008;75:591-600.
ABSTRACT | FULL TEXT  

Genotyping Has a Minor Role in Selecting Therapy for Congenital Long-QT Syndromes at Present
Vincent
Circ Arrhythmia Electrophysiol 2008;1:227-233.
FULL TEXT  

The Year in Review of Clinical Cardiac Electrophysiology
Scheinman and Keung
J Am Coll Cardiol 2008;51:2075-2081.
FULL TEXT  

KCNQ1 and KCNE1 in the IKs Channel Complex Make State-dependent Contacts in their Extracellular Domains
Xu et al.
J. Gen. Physiol. 2008;131:589-603.
ABSTRACT | FULL TEXT  

Prevalence and significance of an isolated long QT interval in elite athletes
Basavarajaiah et al.
Eur Heart J 2007;28:2944-2949.
ABSTRACT | FULL TEXT  

Role of the S6 C-terminus in KCNQ1 channel gating
Boulet et al.
J. Physiol. 2007;585:325-337.
ABSTRACT | FULL TEXT  

Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function
Lehnart et al.
Circulation 2007;116:2325-2345.
ABSTRACT | FULL TEXT  

Common Genetic Variation in KCNH2 Is Associated With QT Interval Duration: The Framingham Heart Study
Newton-Cheh et al.
Circulation 2007;116:1128-1136.
ABSTRACT | FULL TEXT  

Genetic Testing in Cardiovascular Disease
Robin et al.
J Am Coll Cardiol 2007;50:727-737.
ABSTRACT | FULL TEXT  

SCN4B-Encoded Sodium Channel 4 Subunit in Congenital Long-QT Syndrome
Medeiros-Domingo et al.
Circulation 2007;116:134-142.
ABSTRACT | FULL TEXT  

Nonsense Mutations in hERG Cause a Decrease in Mutant mRNA Transcripts by Nonsense-Mediated mRNA Decay in Human Long-QT Syndrome
Gong et al.
Circulation 2007;116:17-24.
ABSTRACT | FULL TEXT  

Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?
Hofman et al.
Eur Heart J 2007;28:575-580.
ABSTRACT | FULL TEXT  

Clinical diagnosis of long QT syndrome: back to the caliper
Rossenbacker and Priori
Eur Heart J 2007;28:527-528.
FULL TEXT  

Secondary Structure of a KCNE Cytoplasmic Domain
Rocheleau et al.
J. Gen. Physiol. 2006;128:721-729.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
Developed in Collaboration With the European Heart et al.
J Am Coll Cardiol 2006;48:1064-1108.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
Developed in Collaboration With the European Heart et al.
J Am Coll Cardiol 2006;48:e247-e346.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
Zipes et al.
Eur Heart J 2006;27:2099-2140.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:746-837.
FULL TEXT  

Molecular Underpinning of "Good Luck"
Priori and Napolitano
Circulation 2006;114:360-362.
FULL TEXT  

A Streamlined Approach to Genetic Screening for Long-QT Syndrome?
Journal Watch Cardiology 2006;2006:4-4.
FULL TEXT  

Efficient Genotyping for Congenital Long QT Syndrome
Kaufman
JAMA 2005;294:3027-3028.
FULL TEXT